Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Obstet Gynecol. 2018 Oct;132(4):961–971. doi: 10.1097/AOG.0000000000002785

Figure 3.

Figure 3.

Use of T2-weighted images, dynamic magnetic resonance imaging with contrast enhancement, and diffusion weighted imaging (with inset apparent diffusion coefficient map) for leiomyoma or leiomyosarcoma diagnosis. Benign leiomyoma: mildly heterogeneous low T2 signal (A), early and heterogeneous avid enhancement (B) no significant restricted diffusion (C). Degenerated leiomyoma: heterogeneous high T2-weighted signal (D) T1-weighted imaging with fat saturation shows homogeneous hypoenhancement (E) heterogeneous diffusion restriction (F). Leiomyosarcoma: infiltrative, ill-defined mass with intermediate T2 signal (G) enhancement of the viable tumoral tissue (H) and hyperintense on high B-value imaging with subsequent restricted dark signal on the apparent diffusion coefficient map (I).